CCND1 and Miyoshi myopathy: Instead, activating mutations in SF3B1 and KIT, loss of CDKN2A, PTEN, or SPRED1, as well as amplification of CDK4, TERT, KIT, MDM2, or CCND1, are more common in MM (16).